Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marcos Barcelos de Pinho"'
Autor:
Aline Rangel Pozzo, Fernanda Costas Casal de Faria, Luize Otero de Carvalho, Marcos Barcelos de Pinho, Raquel Ciuvalschi Maia
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 39, Iss 4, Pp 368-371
Externí odkaz:
https://doaj.org/article/d66706e4e0da4a0db5f045dee3af0d8b
Publikováno v:
Biotechnology letters. 42(12)
To compare different approaches for the expression of an anti-PCSK9 biosimilar monoclonal antibody (mAb) in CHO cells using IRES-mediated tricistronic plasmid vectors combining different signal peptides, IRES elements and selection markers. Transient
Autor:
Fernanda Costas Casal de Faria, Chaquip D. Netto, Paulo Rr Costa, Maria Eduarda Bento Leal, Paula Sabbo Bernardo, Marcos Barcelos de Pinho, Raquel Ciuvalschi Maia
Publikováno v:
Archives of Clinical and Biomedical Research.
Chronic myeloid leukemia (CML), a myeloproliferative disorder characterized by the BCR-ABL oncoprotein, presents its treatment based on tyrosine kinase inhibitors (TKIs), mainly imatinib. However, despite its clinical success, almost 30% of all CML p
Autor:
Marcos Barcelos de Pinho, Fernanda Costas Casal de Faria, Raquel Ciuvalschi Maia, Luize Otero de Carvalho, Aline Rangel Pozzo
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia, Vol 39, Iss 4, Pp 368-371
Revista Brasileira de Hematologia e Hemoterapia, Vol 39, Iss 4, Pp 368-371
Autor:
Thaís Messias Mac-Cormick, Flavio Eduardo Pinto-Silva, Miguel Angelo Martins Moreira, Mateus dos Santos Mota, Vivian M. Rumjanek, Marcos Barcelos de Pinho, Nathalia Daflon-Yunes, Carolina Bagni
Publikováno v:
Leukemia research. 38(8)
Resistance to chemotherapy is one of the most relevant aspects of treatment failure in cancer. Cell lines are used as models to study resistance. We analyzed the transcriptional profile of two multidrug resistant (MDR) cell lines (Lucena 1 and FEPS)